{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/16/3312445/0/en/Acumen-Pharmaceuticals-Announces-Nomination-of-Two-Enhanced-Brain-Delivery-EBD-Development-Candidates-for-the-Treatment-of-Alzheimer-s-Disease.html", "message": "News view counter 801579 successfully enlarged"}